Statement of Work FY 27 Kent Low Energy RP Cleveland and Kent - Draft

STATEMENT OF WORK (SOW)

as of 10/19/2026

Contract Number:
Task Order Number:
IFCAP Tracking Number:

(completed by the CO at time of award)
(completed by the CO at time of award if a TO)

1. Contracting Officer’s Representative (COR).
Name:
Section:
Address:
Phone Number:
E-Mail Address:

TBD
TBD
TBD
TBD
TBD

2. Contract Title.
Low energy radiopharmaceuticals (non-fluorodeoxyglucose F 18 agents), unit doses for patient care at VA Northeast Ohio Healthcare System and VA Kent Imaging and Infusion Center. A base contract plus 4 option years is recommended due to the constant need of radiopharmaceuticals for diagnostic imaging.
3. Background.
The VA Northeast Ohio Healthcare system, Kent, Ohio has a requirement for Radiopharmaceutical Isotopes (non-fluorodeoxyglucose F 18 agents), for patient care. The Contractor is to provide Unit Dose Radiopharmaceutical products as listed herein, as requested by authorized VA staff, in accordance with Public Law 104-262 and 38 USC 8153 to support the VA.
4. Scope.
Contractor will provide products for routine (non-emergent) and emergent orders (aka Emergencies). Emergencies are requested during and outside of regular work hours (Monday through Friday 06:30am to 4:30pm) requiring delivery within 120 minutes after receipt of phoned, faxed, or electronic orders from VA. VA requires prompt processing of Tc-99m tagged WBC Orders, White Blood Cell Count (aka WBC’s). Quantities are expressed as estimates and may vary based on patient demand. The Contractor is to follow generally accepted standard practices for the industry and regulation for the preparation, transportation, and delivery of Radiopharmaceuticals. These may include but are not limited to the Society of Nuclear Medicine and Molecular

Imaging (SNMMI), Food and Drug Administration (FDA), Nuclear Regulatory Commission (NRC), Center for Disease Control (CDC), Untied States Pharmacopeia (USO), and Joint Commission (JC).
The Contractor shall label all supplies as to the amount of radiopharmaceutical, preparation time, expiration time, date, etc. and provide a bar code label to facilitate scanning data into a nuclear medicine information system (NMIS). Each syringe and vial that contains unsealed byproduct material must be labeled to identify the radioactive drug, RX number and calibration time. Each vial shield and syringe shield must also be correctly labeled.
The Contractor will be furnished the names of the individuals authorized to purchase